Abstract
The aim of the study was to evaluate the usefulness of Holter monitoring for the detection of silent myocardial ischemia (SMI) in elderly type 2 diabetic patients with hypertension and the possible relationship between SMI and cardiovascular autonomic neuropathy (CAN). Two hundred and forty-three asymptomatic outpatients, aged 65–75 years, with type 2 diabetes and essential hypertension underwent 24-h ECG monitoring and 5 tests for the evaluation of both parasympathetic (heart rate variability, response to breath deeping, and Valsalva manoeuvre) and sympathetic (cold pressor test and orthostatic hypotension test) autonomic function. A total of 518 asymptomatic episodes of ST depression during Holter monitoring indicative of SMI were detected in 51 of the 243 studied patients (20.9 %). None of the patients with ST depression episodes exhibited a normal response to at least one of the evaluated autonomic function tests, whereas 22 of the 192 patients without ST changes (11.4 %) exhibited a normal response to all tests. Abnormality in both parasympathetic and sympathetic function test responses was found in 94.1 % of patients with ST depression episodes vs 26.1 % of those without ST changes (P < 0.001). Statistical evaluation of the relationship between the abnormal response to single autonomic function test and episodes of ST depression was highly significant for all the 5 tests (P < 0.001). These results indicate that: (a) Holter monitoring enables to detect ST segment changes indicative of SMI in 20.9 % of elderly diabetic patients with hypertension; (b) the presence of autonomic cardiac dysfunction in these patients suggests a role of diabetic neuropathy in the pathogenesis of SMI; and (c) findings of severe autonomic dysfunction in more than 25 % of patients without ST depression episodes suggest that these patients might be at risk of myocardial ischemia and should possibly be addressed to closer specialistic evaluation, since Holter monitoring might have not detected SMI in these patients due to its low sensitivity and relatively short duration of recordings.
Similar content being viewed by others
References
Garcia MJ, McNamara PM, Gordon T, Kannel WB (1974) Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23(2):105–111
Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl 2):S14–S21
Jacoby RM, Nesto RW (1992) Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol 20(3):736–744
Kosuga T, Komukai K, Miyanaga S, Kubota T, Nakata K, Suzuki K, Yamada T, Yoshida J, Kimura H, Yoshimura M (2016) Diabetes is a predictor of coronary artery stenosis in patients hospitalized with heart failure. Heart Vessels 31(5):671–676
Cohn PF (1985) Silent myocardial ischemia: classification, prevalence, and prognosis. Am J Med 79(3A):2–6
Chiariello M, Indolfi C, Cotecchia MR, Sifola C, Romano M, Condorelli M (1985) Asymptomatic transient ST changes during ambulatory ECG monitoring in diabetic patients. Am Heart J 110(3):529–534
Koistinen MJ (1990) Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ 301(6743):92
Bax JJ, Bonow RO, Tschöpe D, Inzucchi SE, Barrett E, Global Dialogue Group for the Evaluation of Cardiovascular Risk in Patients With Diabetes (2006) The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 48(4):754–760
Zhang L, Li H, Zhang S, Jaacks LM, Li Y, Ji L (2014) Silent myocardial ischemia detected by single photon emission computed tomography (SPECT) and risk of cardiac events among asymptomatic patients with type 2 diabetes: a meta-analysis of prospective studies. J Diabetes Complicat 28(3):413–418
Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE, Detection of Ischemia in Asymptomatic Diabetics Investigators (2004) Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27(8):1954–1961
Valensi P, Pariès J, Brulport-Cerisier V, Torremocha F, Sachs RN, Vanzetto G, Cosson E, Lormeau B, Attali JR, Maréchaud R, Estour B, Halimi S (2005) Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care 28(11):2722–2727
Osawa K, Miyoshi T, Oe H, Sato S, Nakamura K, Kohno K, Morita H, Kanazawa S, Ito H (2016) Association between coronary artery calcification and left ventricular diastolic dysfunction in elderly people. Heart Vessels 31(4):499–507
Faerman I, Faccio E, Milei J, Nuñez R, Jadzinsky M, Fox D, Rapaport M (1997) Autonomic neuropathy and painless myocardial infarction in diabetic patients. Histologic evidence of their relationship. Diabetes 26(12):1147–1158
Niakan E, Harati Y, Rolak LA, Comstock JP, Rokey R (1986) Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy. Arch Intern Med 146(11):2229–2230
Murray DP, O’Brien T, Mulrooney R, O’Sullivan DJ (1990) Autonomic dysfunction and silent myocardial ischaemia on exercise testing in diabetes mellitus. Diabet Med 7(7):580–584
Acharya DU, Shekhar YC, Aggarwal A, Anand IS (1991) Lack of pain during myocardial infarction in diabetics—is autonomic dysfunction responsible? Am J Cardiol 68(8):793–796
O’Sullivan JJ, Conroy RM, MacDonald K, McKenna TJ, Maurer BJ (1991) Silent ischaemia in diabetic men with autonomic neuropathy. Br Heart J 66(4):313–315
Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW (1991) Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 67(13):1073–1078
Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26(5):1553–1579
Crawford-Achour E, Roche F, Pichot V, Celle S, Barthélémy JC, Chouchou F (2016) Sleep-related autonomic overactivity in a general elderly population and its relationship to cardiovascular regulation. Heart Vessels 31(1):46–51
Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett EJ, ADA (2007) Screening for coronary artery disease in patients with diabetes. Diabetes Care 30(10):2729–2736
Upchurch CT, Barrett EJ (2012) Clinical review: screening for coronary artery disease in type 2 diabetes. J Clin Endocrinol Metab 97(5):1434–1442
Puel J, Valensi P, Vanzetto G, Lassmann-Vague V, Monin JL, Moulin P, Ziccarelli Ch, Mayaudon H, Ovize M, Bernard S, Van Belle E, Halimi S, ALFEDIAM, SFC (2004) Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. Diabetes Metab 30(3 Pt 3):3S3–3S18
American Diabetes Association (2013) Standards of medical care in diabetes—2013. Diabetes Care 36:S11–S66
Hennessy TG, Codd MB, Kane G, McCarthy C, McCann HA, Sugrue DD (1997) Evaluation of patients with diabetes mellitus for coronary artery disease using dobutamine stress echocardiography. Coron Artery Dis 8(3–4):171–174
Chanudet X, Bonnevie L, Bauduceau B (2007) Coronary heart disease and cardiovascular autonomic neuropathy in the elderly diabetic. Diabetes Metab 33(Suppl 1):S19–S31
Harris GD, White RD (2007) Exercise stress testing in patients with type 2 diabetes: when are asymptomatic patients screened? Clin Diabetes 25:126–130
Schang SJ Jr, Pepine CJ (1977) Transient asymptomatic S-T segment depression during daily activity. Am J Cardiol 39(3):396–402
Cecchi AC, Dovellini EV, Marchi F, Pucci P, Santoro GM, Fazzini PF (1983) Silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with effort angina. J Am Coll Cardiol 1(3):934–939
Gibson CM, Ciaglo LN, Southard MC, Takao S, Harrigan C, Lewis J, Filopei J, Lew M, Murphy SA, Buros J (2007) Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: a review. J Thromb Thrombolysis 23(2):135–145
Hume L, Oakley GD, Boulton AJ, Peach M, Hardisty CA, Ward JD (1986) Ambulatory monitoring of the ST segment in diabetic men with and without peripheral neuropathy. Diabet Med 3(6):545–548
Marín Huerta E, Rayo I, Lara JI, Cuéllar L, de la Calle H, Romero J, del Río A, Muela A, Aza V (1989) Silent myocardial ischemia during Holter monitoring in patients with diabetes mellitus. Rev Esp Cardiol 42(8):519–529
Aronow WS, Mercando AD, Epstein S (1992) Prevalence of silent myocardial ischemia detected by 24-hour ambulatory electrocardiography, and its association with new coronary events at 40-month follow-up in elderly diabetic and nondiabetic patients with coronary artery disease. Am J Cardiol 69(5):555–556
Jermendy G, Dávidovits Z, Khoór S (1993) Connection between painless abnormal ST-deflection and autonomic neuropathy in diabetes mellitus. Orv Hetil 134(2):65–69
Nakao YM, Ueshima K, Nohara R, Mizunuma Y, Segawa I, Tanaka-Mizuno S, Yasuno S, Nakao K, Hiramori K, Kihara Y (2015) Holter monitoring for the screening of cardiac disease in diabetes mellitus: the non-invasive Holter monitoring observation of new cardiac events in diabetics study. Diab Vasc Dis Res 12(6):396–404
Karayannis G, Giamouzis G, Cokkinos DV, Skoularigis J, Triposkiadis F (2012) Diabetic cardiovascular autonomic neuropathy: clinical implications. Expert Rev Cardiovasc Ther 10(6):747–765
Oakley I, Emond L (2011) Diabetic cardiac autonomic neuropathy and anesthetic management: review of the literature. AANA J 79(6):473–479
Jyotsna VP, Sahoo A, Sreenivas V, Deepak KK (2009) Prevalence and pattern of cardiac autonomic dysfunction in newly detected type 2 diabetes mellitus. Diabetes Res Clin Pract 83(1):83–88
Malliani A, Lombardi F (1982) Consideration of the fundamental mechanisms eliciting cardiac pain. Am Heart J 103(4 Pt 1):575–578
Langer A, Freeman MR, Josse RG, Armstrong PW (1995) Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 25(3):610–618
Turpeinen AK, Vanninen E, Kuikka JT, Uusitupa MI (1996) Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM. Diabetes Care 19(10):1083–1090
Koistinen MJ, Airaksinen KE, Huikuri HV, Pirttiaho H, Linnaluoto MK, Ikäheimo MJ, Takkunen JT (1992) Asymptomatic coronary artery disease in diabetes: associated with autonomic neuropathy? Acta Diabetol 28(3–4):199–202
Airaksinen KE (2001) Silent coronary artery disease in diabetes—a feature of autonomic neuropathy or accelerated atherosclerosis? Diabetologia 44(2):259–266
Rosen SD, Camici PG (2000) The brain–heart axis in the perception of cardiac pain: the elusive link between ischaemia and pain. Ann Med 32(5):350–364
Vinik AI, Ziegler D (2007) Diabetic cardiovascular autonomic neuropathy. Circulation 115(3):387–397
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Bosone, D., Fogari, R., Ramusino, M.C. et al. Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients. Heart Vessels 32, 507–513 (2017). https://doi.org/10.1007/s00380-016-0898-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-016-0898-7